Key result
Low-dose neuroleptic treatment was associated with an annual neuroleptic malignant syndrome frequency of 0.07%, occurring in only 1 of 1,470 patients at a short-term psychiatric hospital.
Why the study?
What is the frequency of neuroleptic malignant syndrome in patients treated with neuroleptics at a short-term psychiatric hospital?
What is the frequency of neuroleptic malignant syndrome in patients treated with neuroleptics at a short-term psychiatric hospital?
The annual frequency of neuroleptic malignant syndrome in a short-term psychiatric hospital using low-dose neuroleptics was very low at 0.07%.
Answers are grounded in this paper and cite their sources.
Low NMS frequency with low-dose neuroleptics may inform risk discussions in acute care; leaves open confirmation in larger, diverse cohorts.
Of 1,470 patients treated with neuroleptics during 1 year at a private psychiatric hospital, only one patient developed neuroleptic malignant syndrome--an annual frequency of 0.07%. Use of low doses of neuroleptics may account for this frequency, which is below recent estimates.
No takes yet. Share an insight, caveat, or question.
Gelenberg et al. (1988) studied this question. Low-dose neuroleptic treatment was associated with an annual neuroleptic malignant syndrome frequency of 0.07%, occurring in only 1 of 1,470 patients at a short-term psychiatric hospital.
Synapse has enriched 10 related papers. Consider them for comparative context: